Chester County News and Community Website
LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) recently appointed Ian Blackman as chief financial officer as the company works to complete a planned acquisition of regenerative biomaterial assets from Celularity …
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) recently closed its previously announced license and acquisition of a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU) and launched a …
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) has rescheduled its shareholder update conference call to April 23, 2026, at 4:30 p.m. ET, as it revises financing plans tied to a …
NEXGEL Reschedules Shareholder Call, Revises Celularity Financing Read More LANGHORNE, PA — NEXGEL Inc. (Nasdaq: NXGL) has rescheduled its shareholder update conference call to April 15, 2026, at 4:30 p.m. Eastern time as it revises financing plans tied to …
NEXGEL Reschedules Shareholder Call, Revises Financing Plan Read More LANGHORNE, PA — NEXGEL Inc. (Nasdaq: NXGL) said it will pay $15 million upfront to license and acquire a portfolio of regenerative biomaterial products from Celularity Inc. (Nasdaq: CELU), with …
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio Read More LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) announced it has signed a definitive agreement to license and acquire a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU), a …
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio Read More LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) announced it has secured $1.797 million in financing related to a potential acquisition targeted for the first quarter of 2026, according to a …
NEXGEL Secures $1.8 Million Financing for Potential Acquisition Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) said its planned spin-off, NexGelRx, has secured strategic investments from Eric Gruntfest and Ariel Imas of Diesis Holdings, a move aimed at strengthening …
NEXGEL Spin-Off Draws Strategic Capital as NexGelRx Sharpens Focus Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) said it has spun off select drug delivery assets into a new entity, NexGelRx, a move designed to unlock value from its proprietary …
NEXGEL Spins Off Rx Unit, Locks In Royalties and Equity Without Dilution Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) reported third quarter 2025 results showing stable revenue and improved margins as the hydrogel manufacturer continued to advance both its contract manufacturing and …
Hydrogel Innovator NEXGEL Posts Steady Q3 as Margin Gains Offset Flat Revenue Read More